Prestige Consumer Healthcare Inc. (PBH)
NYSE NYSE Primary 
XFRA 
Prestige Consumer Healthcare Inc. (PBH) Q3 2026 Earnings Call Transcript
Prestige Consumer Healthcare Inc. (PBH) Q3 2026 Earnings Call Transcript
Prestige Consumer Healthcare (PBH) Q3 Earnings Lag Estimates
Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.14 per share, missing the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.22 per share a year ago.
PBH vs. A: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Agilent Technologies (A). But which of these two companies is the best option for those looking for undervalued stocks?
PBH or ABT: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks is more attractive to value investors?
PBH vs. ABT: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
Is This the Right Time to Add PBH Stock to Your Portfolio?
Prestige Consumer Healthcare benefits from e-commerce momentum, acquisitions and solid solvency, even as inflation and tariff costs pose near-term risks.
PBH vs. ABT: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
PBH or ABT: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks is more attractive to value investors?
Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 18th Annual Global Consumer Staples Conference 2025 Transcript
Prestige Consumer Healthcare Inc. (NYSE:PBH ) Barclays 18th Annual Global Consumer Staples Conference 2025 September 4, 2025 12:45 PM EDT Company Participants Ron Lombardi - Chairman, President & CEO Christine Sacco - CFO & COO Presentation Ron Lombardi Chairman, President & CEO Okay. Good afternoon, everyone.
Premium Brands: Long Climb To $10 Billion
Premium Brands continues steady mid-single-digit organic growth, with Q2 revenue up 12.4% year-over-year, but faces margin pressure from higher interest and investment cycle. The company's high leverage (Debt/EBITDA ~4x) and ongoing M&A strategy weigh on net profit and cash flow, despite improved free cash flow this quarter. Long-term targets are ambitious ($10B revenue, $1–1.2B EBITDA by FY 2027), but current valuation and debt levels limit upside versus broader market returns.
Prestige Consumer Healthcare Inc. (PBH) Q1 2026 Earnings Call Transcript
Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q1 2026 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Christine Sacco - CFO & COO Philip David Terpolilli - Director of Investor Relations Ronald M. Lombardi - Chairman, President & CEO Conference Call Participants Anthony Chester Lebiedzinski - Sidoti & Company, LLC Douglas Matthai Lane - Water Tower Research LLC Glenn West - William Blair & Company L.L.C.
Prestige Consumer Healthcare (PBH) Misses Q1 Earnings and Revenue Estimates
Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $0.95 per share, missing the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $0.9 per share a year ago.
